Evidence map›Paper›PMID 40427111›Full record

ArticleCancers2025

MoLEP vs. HoLEP for BPH: A 3-Year Greek Single-Center Retrospective Comparative Cohort Study on 1368 Cases.

Panayiotis Veveloyiannis, Nikolaos Bafaloukas, Dimitra S Mouliou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Panayiotis VeveloyiannisMinimal Invasive Urology Clinic MITERA Hospital HHG Group, 15123 Marousi, Greece.
Nikolaos BafaloukasForth Urological Department, IASO Hospital, 15123 Marousi, Greece.
Dimitra S MouliouIndependent Researcher, 38500 Volos, Greece.ORCID 0000-0003-3179-4010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHolmium Laser Enucleation of the Prostate (HoLEP) is an established treatment for benign prostatic hyperplasia (BPH). Pulse-modulated lasers, like MOSES technology (MoLEP), may enhance the procedure's efficiency and safety.

methodsA 3-year single-center retrospective comparative study was conducted on 1368 patients treated with HoLEP/MoLEP at MITERA Hospital.

resultsA total of 688 patients were treated with HoLEP and 680 with MoLEP. Compared to HoLEP, MoLEP demonstrated shorter surgical (50.5 min [IQR 33-60] vs. 58 min [IQR 46-69],

conclusionsMoLEP offered significant advantages over HoLEP in this study.

Indexed as

benign prostatic hyperplasiacomplicationsenucleation timeHoLEPIPSSMoLEPPSAPVRQmaxQoL

Identifiers

PMID40427111
PMCPMC12110212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.